Prana Thoracic
Venture Round in 2024
Prana Thoracic, Inc. is a Houston-based medical device startup focused on addressing the challenges of early intervention in lung cancer, which remains a leading cause of cancer-related deaths in the United States. The company aims to enhance screening and diagnosis by developing advanced surgical tools that facilitate the capture and analysis of small, suspicious lung nodules. Their innovative device employs a tissue-sparing electrosurgical technique that utilizes bipolar radiofrequency energy, allowing for simultaneous cutting and sealing. This approach minimizes the risk of complications associated with traditional methods, thereby improving the prospects for early detection and treatment. By providing physicians with more effective tools, Prana Thoracic seeks to revolutionize the management of lung cancer, ensuring that patients receive timely interventions and improving overall survival rates.
Nanochon
Seed Round in 2024
Nanochon is focused on creating innovative implantable medical devices designed to address cartilage damage in joints. Utilizing advanced 3D printing techniques and a unique nanomaterial, the company aims to develop solutions that not only replace lost and damaged cartilage but also promote the growth of new tissue. This approach allows medical practitioners to access cost-effective and on-demand devices that enhance treatment outcomes, particularly for young and active patients suffering from knee injuries and diseases. Through its technology, Nanochon seeks to improve the overall quality of care in orthopedics.
Nanochon
Venture Round in 2023
Nanochon is focused on creating innovative implantable medical devices designed to address cartilage damage in joints. Utilizing advanced 3D printing techniques and a unique nanomaterial, the company aims to develop solutions that not only replace lost and damaged cartilage but also promote the growth of new tissue. This approach allows medical practitioners to access cost-effective and on-demand devices that enhance treatment outcomes, particularly for young and active patients suffering from knee injuries and diseases. Through its technology, Nanochon seeks to improve the overall quality of care in orthopedics.
Virtual Incision
Series C in 2023
Virtual Incision is focused on developing innovative surgical solutions, specifically through its miniaturized robotic support device designed for colon resection. The company's flagship product, the MIRA (Miniaturized In vivo Robotic Assistant) Platform, is a pioneering device that aims to streamline surgical procedures by allowing for quick setup in the operating room without the need for heavy equipment. This technology is intended to assist surgeons in improving clinical outcomes while also addressing healthcare costs. Virtual Incision's approach represents a significant advancement in robotic-assisted surgery, with plans for future applications beyond colon resection.
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.
Shoulder Innovations
Series D in 2023
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed a Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical challenge of reliable fixation for glenoid implants. This technology not only enhances post-surgical implant stability, reducing the risk of revision surgeries, but also simplifies surgical instrumentation, which can lead to shorter operative times and lower costs. Shoulder Innovations markets its products through distribution partners across the United States, aiming to improve patient care and reduce overall healthcare costs.
SpinTech MRI
Series A in 2022
SpinTech MRI is a developer of an advanced MRI imaging software platform designed to significantly reduce the time required for brain imaging while enhancing the visualization and automatic detection of critical biomarkers for neurological conditions. These conditions include traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and stroke, which often go undetected with existing methods. By transforming advanced research techniques into practical clinical applications, SpinTech MRI's platform integrates seamlessly with virtually any MRI machine to provide standardized, high-quality images and quantitative biomarkers. This innovative approach aids clinicians in detecting microbleeds and quantifying neuromelanin content, ultimately improving patient outcomes and maximizing the return on investment for expensive imaging equipment. The team comprises physicists, engineers, and entrepreneurs dedicated to advancing imaging technology for patients suffering from neurological diseases.
Strados Labs
Seed Round in 2021
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
Deepstash
Seed Round in 2020
Deepstash operates a knowledge-based platform that focuses on delivering curated, bite-sized ideas extracted from a variety of online sources, including articles, videos, and podcasts. The platform is designed to help users navigate the overwhelming amount of information available on the internet by allowing them to save, organize, and share insights that resonate with them. Users can explore content aimed at enhancing their skills, productivity, and overall well-being. With a passionate community dedicated to uncovering meaningful insights, Deepstash emphasizes the importance of ideas as building blocks for personal and societal improvement. The Deepstash app is accessible on both mobile platforms and the web, making it convenient for users to engage with content that matters to them anytime and anywhere.
Embody, Inc., established in 2014 and based in Norfolk, Virginia, is a regenerative medicine company specializing in the development and commercialization of implantable medical devices. Its primary focus is addressing unmet demands in soft tissue restoration and regeneration, specifically for tendon and ligament repair. Embody's innovative collagen-based microfiber implants are designed to replicate the biological and biomechanical properties of native tissue, aiming to restore pre-injury performance for a wide range of patients, including warfighters, athletes, and those suffering from sports injuries. The company employs advanced technologies such as microfluidic biofabrication and electrospinning in its product development.
Genesis Software Innovations
Seed Round in 2019
Genesis Software Innovations develops innovative and integrated software tools focused around surgical centers in the orthopedic space. The company's vision is to create great software tools that give medical professionals the information they need to produce repeatedly excellent, surgical results.
Magnesium Development
Series A in 2019
Magnesium Development Company, LLC is a medical device developer based in Grand Rapids, Michigan, specializing in sports medicine orthopedics. Founded in 2014, the company focuses on innovative applications of its BioMg 250 magnesium alloy technology, which merges the strength and handling characteristics of traditional metals with the ability to fully absorb in the body. This technology addresses several challenges in surgical repairs, such as delayed resorption, mechanical failures, and complications related to existing materials. By providing solutions for soft tissue injuries in areas like the knee, shoulder, and lower extremities, Magnesium Development aims to enhance recovery outcomes and support patients' return to active lifestyles. As the demand for effective treatments in sports-related injuries continues to rise, the company’s breakthroughs in resorbable metal alloys position it as a key player in advancing orthopedic care.
SpinTech MRI
Venture Round in 2018
SpinTech MRI is a developer of an advanced MRI imaging software platform designed to significantly reduce the time required for brain imaging while enhancing the visualization and automatic detection of critical biomarkers for neurological conditions. These conditions include traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and stroke, which often go undetected with existing methods. By transforming advanced research techniques into practical clinical applications, SpinTech MRI's platform integrates seamlessly with virtually any MRI machine to provide standardized, high-quality images and quantitative biomarkers. This innovative approach aids clinicians in detecting microbleeds and quantifying neuromelanin content, ultimately improving patient outcomes and maximizing the return on investment for expensive imaging equipment. The team comprises physicists, engineers, and entrepreneurs dedicated to advancing imaging technology for patients suffering from neurological diseases.
Medical Ingenuities
Venture Round in 2018
Medical Ingenuities, LLC is a medical device company based in Wheaton, Illinois, specializing in solutions that enhance patient care and healthcare systems. The company has developed the PH Band, a radial artery occlusion device that facilitates achieving and confirming hemostasis while providing real-time feedback on radial artery patency. This device is designed to assist medical personnel in monitoring blood flow after trans-radial procedures, thereby reducing the risk of complications associated with artery occlusion. The PH Band streamlines the workflow for healthcare providers and optimizes patient outcomes through its innovative design and functionality.
Shoulder Innovations
Series A in 2018
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed a Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical challenge of reliable fixation for glenoid implants. This technology not only enhances post-surgical implant stability, reducing the risk of revision surgeries, but also simplifies surgical instrumentation, which can lead to shorter operative times and lower costs. Shoulder Innovations markets its products through distribution partners across the United States, aiming to improve patient care and reduce overall healthcare costs.
Shoulder Innovations
Series A in 2017
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed a Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical challenge of reliable fixation for glenoid implants. This technology not only enhances post-surgical implant stability, reducing the risk of revision surgeries, but also simplifies surgical instrumentation, which can lead to shorter operative times and lower costs. Shoulder Innovations markets its products through distribution partners across the United States, aiming to improve patient care and reduce overall healthcare costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.